A novel WINDOW of opportunity for young mantle cell lymphoma patients
iwNHL 2016: Highlights from Day 1
Catherine Bollard et al.
Venetoclax and ibrutinib and drug combinations for CLL
The Role of the B-Cell Receptor and Other Signaling Pathways in CLL
Advancements in APL treatment: oral ATO, MRD and treatment objectives